Update on Ivermectin; now in demand

Martha Ferris said:
Larger trials will be needed to confirm these preliminary findings." A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness - PubMed (nih.gov)
Click to expand...
Those trials have been completed and reviewed. The consensus is one 2.5mg dose (if I remember right) every other day for 3 doses, then one dose a week.

It's in one of the videos in the original post here. The shorter one, I think.
 

Dr. Campbell asks (again) why is WHO still not recommending Ivermectin as a front-line therapeutic, and why isn't the media talking about it?

India, Peru, and Mexico show thousands of case studies each; Ivermectin keeps patients with covid out of hospital, and actually prevents contracting covid in the first place. (vid is abt 25min long)
 
FYI, unconfirmed but on the wires is news that India's health regulators have removed invermectin from its covid-19 protocols. I have no links at this time. If anyone can find a source, I'd like to know what it is. If the news is true, I'd love to know why the about-face.
 
Findings regarding myocarditis/pericarditis after vaccine. Data shows mostly men and mostly young adults are experiencing heart problems after vaccine, especially after the 2nd vaccine.

 
I saw this today in the Jerusalem Post: Israeli scientist says COVID-19 could be treated for under $1/day

Ivermectin, a drug used to fight parasites in third-world countries, could help reduce the length of infection for people who contract coronavirus for less than a $1 a day, according to recent research by Sheba Medical Center in Tel Hashomer. Prof. Eli Schwartz, founder of the Center for Travel Medicine and Tropical Disease at Sheba, conducted a randomized, controlled, double-blinded trial from May 15, 2020, through the end of January 2021 to evaluate the effectiveness of ivermectin in reducing viral shedding among nonhospitalized patients with mild to moderate COVID-19.​

- [snip]-​
​
For example, the study published earlier this year in the American Journal of Therapeutics highlighted that ā€œa review by the Front Line COVID-19 Critical Care Alliance summarized findings from 27 studies on the effects of ivermectin for the prevention and treatment of COVID-19 infection, concluding that ivermectin ā€˜demonstrates a strong signal of therapeutic efficacyā€™ against COVID-19.ā€​
​
There was mention in the article of a researcher who argues against the use of ivermectin:

ā€œIvermectin is a chemical therapeutic agent, and it has significant risks associated with it,ā€ he said in a previous interview. ā€œWe should be very cautious about using this type of medication to treat a viral disease that the vast majority of the public is going to recover from even without this treatment.ā€​

It was interesting that said research person would argue caution for a well-known, long studied, heavily-used and cheap drug but not for a new, previously untested vaccine technology. Conflict of interest? There is a lot of money on the table here and ivermectin won't get you any.
 
Murrmurr said:
Even less in their government. Nepal is covid-dire now, too - India's gov't allowed millions of India's migrant workers to go to Nepal, and then told them to get back into India a few weeks later. So they were there long plenty enough to spread the new variant.
Click to expand...
Like our border
 
Equally interesting is this, "a viral disease that the vast majority of the public is going to recover from even without this treatment.ā€
 
Becky1951 said:
Equally interesting is this, "a viral disease that the vast majority of the public is going to recover from even without this treatment.ā€
Click to expand...
I'm reading/hearing this especially in reference to the Delta variant; Viral like "regular" flu viruses, but relatively mild like "regular" flu viruses. And here and there I'm reading it's "not as deadly as 'regular' flu viruses."
 
Murrmurr said:
That'll be like the 14th trial. How many is it going to take? How many for the vaccine?....none. Why? I'm guessing (probably accurately) it's because Ivermectin is dirt cheap, already mass produced, and not owned by a major pharmaceutical company.
Click to expand...
Exactly, the Big Pharmaceutical companies can't make their usual 90% upmarket out of it.
 

You must log in or register to reply here.

Back
Top